Integra LifeSciences (IART) grants EVP 5,590 RSUs vesting over 3 years

Rhea-AI Filing Summary

Singh Harvinder reported acquisition or exercise transactions in this Form 4 filing.

Integra LifeSciences EVP & President, SS Harvinder Singh received a grant of 5,590 restricted stock units (RSUs). The award was made under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan.

Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in three equal annual installments on the first, second, and third anniversaries of the grant date, subject to his continued service. Following this grant, Singh holds 68,883 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Singh Harvinder

Role EVP & President, SS

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	5,590	$0.00	--

Holdings After Transaction: Restricted Stock Units — 68,883 shares (Direct, null)

Footnotes (1)

1. Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Key Figures

RSUs granted: 5,590 RSUs Holdings after grant: 68,883 RSUs Vesting period: 3 years

3 metrics

RSUs granted 5,590 RSUs Grant of restricted stock units to Harvinder Singh

Holdings after grant 68,883 RSUs Total restricted stock units following this transaction

Vesting period 3 years RSUs vest in three equal annual installments

Key Terms

Restricted Stock Units, Equity Incentive Plan, contingent right, vesting

4 terms

Restricted Stock Units financial

"Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan")"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock"

vesting financial

"will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 04:43 PM Accepted by SEC EDGAR 07/06/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singh Harvinder

(Last) (First) (Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President, SS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/01/2026		A		5,590		(2)	(2)	Common Stock	5,590	$0	68,883	D

Explanation of Responses:

1. Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Remarks:

	/s/ Lesha Shinn; Attorney-in-Fact for Harvinder Singh	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Integra LifeSciences (IART) report for Harvinder Singh?

Integra LifeSciences reported that EVP & President, SS Harvinder Singh received a grant of 5,590 restricted stock units. These RSUs are a form of equity compensation that convert into common shares over time if service-based vesting conditions are satisfied.

How many restricted stock units did Harvinder Singh receive from Integra LifeSciences (IART)?

Harvinder Singh received 5,590 restricted stock units from Integra LifeSciences. Each RSU represents a contingent right to receive one share of the company’s common stock, providing equity-based compensation that aligns his interests with long-term shareholder value creation.

What is the vesting schedule for Harvinder Singh’s new Integra LifeSciences RSU grant?

All 5,590 RSUs will vest ratably in three equal annual installments on the first, second, and third anniversaries of the grant date. Vesting is conditioned on Singh’s continued service with Integra LifeSciences through each applicable vesting date.

Did Harvinder Singh buy or sell Integra LifeSciences (IART) shares in this Form 4?

This Form 4 reflects a grant or award of 5,590 RSUs, not an open-market purchase or sale. The transaction is coded as an acquisition related to equity compensation, with no transaction price and no reported market trading activity in this filing.

What are Harvinder Singh’s Integra LifeSciences holdings after this RSU grant?

After the RSU grant, Harvinder Singh directly holds 68,883 restricted stock units. These RSUs each represent a contingent right to receive one share of Integra LifeSciences common stock as they vest over time under the equity incentive plan’s terms.